MARKET

RPRX

RPRX

Royalty Pharma plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

50.35
-1.50
-2.89%
After Hours: 50.25 -0.1 -0.20% 19:40 01/20 EST
OPEN
51.85
PREV CLOSE
51.85
HIGH
51.94
LOW
50.22
VOLUME
3.28M
TURNOVER
--
52 WEEK HIGH
56.50
52 WEEK LOW
34.80
MARKET CAP
29.98B
P/E (TTM)
15.90
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
BRIEF-Minerva Neurosciences And Royalty Pharma Announce Sale Of Seltorexant Royalty For Up To $155 Million
reuters.com · 1d ago
Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences
Royalty Pharma plc (Nasdaq: RPRX) and Minerva Neurosciences, Inc. (Nasdaq: NERV) today announced that Royalty Pharma will acquire Minerva's royalty interest in seltorexant for an upfront payment of $60 million and up to $95 million in additional milestone ...
GlobeNewswire · 1d ago
Royalty Pharma increases quarterly dividend by 13% to 17 cents a share
MarketWatch · 01/08 13:05
Royalty Pharma Announces 13% Dividend Increase
Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2021 of $0.17 per class A share, reflecting a 13% increase in the company's quarterly dividend over the previous quarter's divide...
GlobeNewswire · 01/08 13:00
Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 12
Royalty Pharma plc (Nasdaq: RPRX) today announced that management will present at the 39 Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 10:50 a.m. EST.
GlobeNewswire · 01/07 21:15
Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 12
GlobeNewswire · 01/07 21:15
IPOs to watch in 2021: The 5 most anticipated debuts
2020 was a banner year for U.S. IPOs even amid a global pandemic and financial crisis. Momentum will continue into 2021, with the hotly anticipated debuts of Roblox and Affirm.
Yahoo Finance · 12/23/2020 20:16
Royalty Pharma Announces Charitable Gifts to Support COVID-19 Research at Leading Hospitals and Universities
Royalty Pharma plc (Nasdaq: RPRX) today announced charitable contributions totaling $7,660,000 to support important COVID-19 research at The Rockefeller University, Mount Sinai Health System and Columbia University. This amount includes donations from Roya...
GlobeNewswire · 12/22/2020 13:30
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RPRX. Analyze the recent business situations of Royalty Pharma plc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RPRX stock price target is 52.14 with a high estimate of 56.00 and a low estimate of 47.00.
EPS
Institutional Holdings
Institutions: 169
Institutional Holdings: 158.63M
% Owned: 26.64%
Shares Outstanding: 595.38M
TypeInstitutionsShares
Increased
47
15.39M
New
88
-295.75K
Decreased
16
4.29M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.19%
Pharmaceuticals & Medical Research
-0.03%
Key Executives
Chairman/Chief Executive Officer/Director
Pablo Legorreta
Vice Chairman/Executive Vice President/Director
Christopher Hite
Chief Financial Officer/Executive Vice President
Terrance Coyne
Executive Vice President/General Counsel
George Lloyd
Executive Vice President
James Reddoch
Senior Vice President
Molly Chiaramonte
Senior Vice President
Marshall Urist
Director
M. Germano Giuliani
Director
Rory Riggs
Independent Director
Bonnie Bassler
Independent Director
Errol De Souza
Independent Director
Catherine Engelber
Independent Director
Catherine Engelbert
Independent Director
Henry Fernandez
Independent Director
William Ford
Independent Director
Ted Love
Independent Director
Gregory Norden
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
01/08/2021
Dividend USD 0.17
02/18/2021
10/15/2020
Dividend USD 0.15
11/19/2020
09/02/2020
Dividend USD 0.15
09/14/2020
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About RPRX
Royalty Pharma plc is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in approximately 45 commercial products and four development-stage product candidates.
More

Webull offers kinds of Royalty Pharma plc stock information, including NASDAQ:RPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RPRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RPRX stock methods without spending real money on the virtual paper trading platform.